HAE
Haemonetics Corp
Price:  
95.27 
USD
Volume:  
264,142.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HAE WACC - Weighted Average Cost of Capital

The WACC of Haemonetics Corp (HAE) is 7.6%.

The Cost of Equity of Haemonetics Corp (HAE) is 8.30%.
The Cost of Debt of Haemonetics Corp (HAE) is 4.30%.

Range Selected
Cost of equity 6.60% - 10.00% 8.30%
Tax rate 15.90% - 21.10% 18.50%
Cost of debt 4.00% - 4.60% 4.30%
WACC 6.2% - 9.1% 7.6%
WACC

HAE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.59 0.91
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.60% 10.00%
Tax rate 15.90% 21.10%
Debt/Equity ratio 0.16 0.16
Cost of debt 4.00% 4.60%
After-tax WACC 6.2% 9.1%
Selected WACC 7.6%